← Eichor
Study identifier: NCT05884736 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Confirming Permanent Lack of Blood Flow to the Brain During A-NRP DCC Organ Transplant

Condition: Organ Transplant  ·  Sponsor: Western University, Canada

PhaseN/A
Planned participants30
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This study aims to evaluate the surgical technique used in Abdominal Normothermic Regional Perfusion (A-NRP) in death determination by circulatory criteria (DCC) organ donors. The proposed study will demonstrate that there is no resumption of brain blood flow or activity during the A-NRP procedure. This will be assessed using multimodal neuromonitoring protocol that enables continuous focused monitoring of brain blood flow and activity during A-NRP. This will provide evidence that brain blood flow and activity does not resume during NRP and ensure donor safety in using this technique in standard of care practice.

This description comes directly from the study's public registry record.

Talk to the study team

Crystal Engelage, PhD  ·  519-685-8500  ·  Crystal.Engelage@lhsc.on.ca

Anton Skaro, MD PhD  ·  519-663-2904  ·  Anton.Skaro@lhsc.on.ca

Always discuss trial participation with your own doctor first.

Locations (2)

London Health Sciences CentreLondon, Ontario, CanadaRecruiting
Toronto Western HospitalToronto, Ontario, CanadaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05884736